Report Detail
Global Chikungunya Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4519426 |
- 06 March, 2023 |
- Global |
- 98 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Chikungunya Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Chikungunya fever is an acute infectious disease caused by CHIKV, transmitted by Aedes mosquitoes, characterized by fever, rash and joint pain, and has long-term debilitating effects.
This report is a detailed and comprehensive analysis for global Chikungunya Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Chikungunya Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Chikungunya Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Chikungunya Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Chikungunya Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chikungunya Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chikungunya Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceutical Company Limited, Valneva SE, Moderna Inc, Emergent BioSolutions Inc and Bharat Biotech International Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Chikungunya Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Live-Attenuated Virus Vaccines
Inactivated Viral Vaccine
Recombinant Viral Vaccines
Chimeric-Alphavirus Candidates
Market segment by Application
Child
Adult
Major players covered
Takeda Pharmaceutical Company Limited
Valneva SE
Moderna Inc
Emergent BioSolutions Inc
Bharat Biotech International Limited
Thermis Bioscience GmbH
Auro Vaccine LLC
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chikungunya Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chikungunya Vaccine, with price, sales, revenue and global market share of Chikungunya Vaccine from 2018 to 2023.
Chapter 3, the Chikungunya Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chikungunya Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Chikungunya Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chikungunya Vaccine.
Chapter 14 and 15, to describe Chikungunya Vaccine sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Chikungunya Vaccine
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Chikungunya Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Live-Attenuated Virus Vaccines
- 1.3.3 Inactivated Viral Vaccine
- 1.3.4 Recombinant Viral Vaccines
- 1.3.5 Chimeric-Alphavirus Candidates
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Chikungunya Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Child
- 1.4.3 Adult
- 1.5 Global Chikungunya Vaccine Market Size & Forecast
- 1.5.1 Global Chikungunya Vaccine Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Chikungunya Vaccine Sales Quantity (2018-2029)
- 1.5.3 Global Chikungunya Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Takeda Pharmaceutical Company Limited
- 2.1.1 Takeda Pharmaceutical Company Limited Details
- 2.1.2 Takeda Pharmaceutical Company Limited Major Business
- 2.1.3 Takeda Pharmaceutical Company Limited Chikungunya Vaccine Product and Services
- 2.1.4 Takeda Pharmaceutical Company Limited Chikungunya Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
- 2.2 Valneva SE
- 2.2.1 Valneva SE Details
- 2.2.2 Valneva SE Major Business
- 2.2.3 Valneva SE Chikungunya Vaccine Product and Services
- 2.2.4 Valneva SE Chikungunya Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Valneva SE Recent Developments/Updates
- 2.3 Moderna Inc
- 2.3.1 Moderna Inc Details
- 2.3.2 Moderna Inc Major Business
- 2.3.3 Moderna Inc Chikungunya Vaccine Product and Services
- 2.3.4 Moderna Inc Chikungunya Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Moderna Inc Recent Developments/Updates
- 2.4 Emergent BioSolutions Inc
- 2.4.1 Emergent BioSolutions Inc Details
- 2.4.2 Emergent BioSolutions Inc Major Business
- 2.4.3 Emergent BioSolutions Inc Chikungunya Vaccine Product and Services
- 2.4.4 Emergent BioSolutions Inc Chikungunya Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Emergent BioSolutions Inc Recent Developments/Updates
- 2.5 Bharat Biotech International Limited
- 2.5.1 Bharat Biotech International Limited Details
- 2.5.2 Bharat Biotech International Limited Major Business
- 2.5.3 Bharat Biotech International Limited Chikungunya Vaccine Product and Services
- 2.5.4 Bharat Biotech International Limited Chikungunya Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Bharat Biotech International Limited Recent Developments/Updates
- 2.6 Thermis Bioscience GmbH
- 2.6.1 Thermis Bioscience GmbH Details
- 2.6.2 Thermis Bioscience GmbH Major Business
- 2.6.3 Thermis Bioscience GmbH Chikungunya Vaccine Product and Services
- 2.6.4 Thermis Bioscience GmbH Chikungunya Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Thermis Bioscience GmbH Recent Developments/Updates
- 2.7 Auro Vaccine LLC
- 2.7.1 Auro Vaccine LLC Details
- 2.7.2 Auro Vaccine LLC Major Business
- 2.7.3 Auro Vaccine LLC Chikungunya Vaccine Product and Services
- 2.7.4 Auro Vaccine LLC Chikungunya Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Auro Vaccine LLC Recent Developments/Updates
3 Competitive Environment: Chikungunya Vaccine by Manufacturer
- 3.1 Global Chikungunya Vaccine Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Chikungunya Vaccine Revenue by Manufacturer (2018-2023)
- 3.3 Global Chikungunya Vaccine Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Chikungunya Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Chikungunya Vaccine Manufacturer Market Share in 2022
- 3.4.2 Top 6 Chikungunya Vaccine Manufacturer Market Share in 2022
- 3.5 Chikungunya Vaccine Market: Overall Company Footprint Analysis
- 3.5.1 Chikungunya Vaccine Market: Region Footprint
- 3.5.2 Chikungunya Vaccine Market: Company Product Type Footprint
- 3.5.3 Chikungunya Vaccine Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Chikungunya Vaccine Market Size by Region
- 4.1.1 Global Chikungunya Vaccine Sales Quantity by Region (2018-2029)
- 4.1.2 Global Chikungunya Vaccine Consumption Value by Region (2018-2029)
- 4.1.3 Global Chikungunya Vaccine Average Price by Region (2018-2029)
- 4.2 North America Chikungunya Vaccine Consumption Value (2018-2029)
- 4.3 Europe Chikungunya Vaccine Consumption Value (2018-2029)
- 4.4 Asia-Pacific Chikungunya Vaccine Consumption Value (2018-2029)
- 4.5 South America Chikungunya Vaccine Consumption Value (2018-2029)
- 4.6 Middle East and Africa Chikungunya Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Chikungunya Vaccine Sales Quantity by Type (2018-2029)
- 5.2 Global Chikungunya Vaccine Consumption Value by Type (2018-2029)
- 5.3 Global Chikungunya Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Chikungunya Vaccine Sales Quantity by Application (2018-2029)
- 6.2 Global Chikungunya Vaccine Consumption Value by Application (2018-2029)
- 6.3 Global Chikungunya Vaccine Average Price by Application (2018-2029)
7 North America
- 7.1 North America Chikungunya Vaccine Sales Quantity by Type (2018-2029)
- 7.2 North America Chikungunya Vaccine Sales Quantity by Application (2018-2029)
- 7.3 North America Chikungunya Vaccine Market Size by Country
- 7.3.1 North America Chikungunya Vaccine Sales Quantity by Country (2018-2029)
- 7.3.2 North America Chikungunya Vaccine Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Chikungunya Vaccine Sales Quantity by Type (2018-2029)
- 8.2 Europe Chikungunya Vaccine Sales Quantity by Application (2018-2029)
- 8.3 Europe Chikungunya Vaccine Market Size by Country
- 8.3.1 Europe Chikungunya Vaccine Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Chikungunya Vaccine Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Chikungunya Vaccine Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Chikungunya Vaccine Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Chikungunya Vaccine Market Size by Region
- 9.3.1 Asia-Pacific Chikungunya Vaccine Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Chikungunya Vaccine Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Chikungunya Vaccine Sales Quantity by Type (2018-2029)
- 10.2 South America Chikungunya Vaccine Sales Quantity by Application (2018-2029)
- 10.3 South America Chikungunya Vaccine Market Size by Country
- 10.3.1 South America Chikungunya Vaccine Sales Quantity by Country (2018-2029)
- 10.3.2 South America Chikungunya Vaccine Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Chikungunya Vaccine Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Chikungunya Vaccine Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Chikungunya Vaccine Market Size by Country
- 11.3.1 Middle East & Africa Chikungunya Vaccine Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Chikungunya Vaccine Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Chikungunya Vaccine Market Drivers
- 12.2 Chikungunya Vaccine Market Restraints
- 12.3 Chikungunya Vaccine Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Chikungunya Vaccine and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Chikungunya Vaccine
- 13.3 Chikungunya Vaccine Production Process
- 13.4 Chikungunya Vaccine Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Chikungunya Vaccine Typical Distributors
- 14.3 Chikungunya Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Chikungunya Vaccine. Industry analysis & Market Report on Chikungunya Vaccine is a syndicated market report, published as Global Chikungunya Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Chikungunya Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
